Vitruvias Therapeutics Thyroid Medication
3 stories tracked · latest
News coverage of the Vitruvias Therapeutics Thyroid Medication class action lawsuit, aggregated automatically from public reporting. Each item below is our own summary with a link to the original source — we never reproduce the source article's text.
Recent coverage
Thyroid medication recall upgraded to FDA highest risk level
The FDA elevated the risk classification of a previously recalled thyroid medication due to concerns that it may be excessively potent.
THYROID MEDICATION RECALLED OVER SUPERPOTENCY CONCERNS
Vitruvias Therapeutics has voluntarily recalled one lot of thyroid medication due to concerns that the tablets may be overly potent.
Thyroid tablets could be ‘superpotent,’ warns FDA in urgent recall alert - WKBN.com
The FDA issued an urgent recall alert warning that certain thyroid tablets may be excessively potent.
Coverage above aggregates public news reporting using the GDELT news database and Google News, updated automatically without human review. It is general information, not legal advice, and does not indicate CaseValuation.com represents or is affiliated with any party, law firm, or plaintiff named above. CaseValuation.com is not a law firm. If you believe you're affected by one of these matters, consult a licensed attorney.